Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus

Journal of Endocrinological Investigation

Volumn 35, Issue 5, 2012, Pages 469-472

  Kanazawa, I ^a   Yamaguchi, T ^a   Sugimoto, T ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Dehydroepiandrosterone sulfate; Glycemic control; HbA1c; Insulin like growth factor I; Type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PRASTERONE SULFATE; SOMATOMEDIN C; SULFONYLUREA;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; JAPANESE; LONGITUDINAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

AGED; AGING; BLOOD GLUCOSE; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HORMONES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84863907751     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8033     Document Type: Article

References (39)

1. Vaessen N, Heutink P, Janssen JA, et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001, 50: 637-42. (Pubitemid 32195230)
2. Haffner SM, Moss SE, Klein BE, Klein R. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1996, 19: 1045-50. (Pubitemid 26334250)
3. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996, 45: 91-100. (Pubitemid 26010429)
4. Coleman DL, Leiter EH, Schwizer RW. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982, 31: 830-3. (Pubitemid 12062875)
5. Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997, 82: 3498-505. (Pubitemid 27419111)
6. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 1997, 12: 1272-9. (Pubitemid 27334974)
7. Zhuang HX, Snyder CK, Pu SF, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996, 140: 198-205. (Pubitemid 26254900)
8. Grant MB, Caballero S, Millard WJ. Inhibition of IGF-I and bFGF stimulated growth of human retinal endothelial cells by the analogue, octreotide. A potential treatment for ocular neovascularization. Regul Pept 1993, 48: 267-78.
9. Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 1999, 48: 377-82 (Pubitemid 29061114)
10. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 2007, 18: 1675-81. (Pubitemid 47620319)
11. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin/bone specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes. Calcif Tissue Int 2009, 85: 228-34.
12. Kanazawa I, Yamaguchi T, Sugimoto T. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 2011, 22: 1191-8.
13. Fukui M, Kitagawa Y, Nakamura N, et al. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes. Diabetes Care 2004, 27: 2893-7.
14. Pesaresi M, Maschi O, Giatti S, et al. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav 2010, 57: 46-55.
15. Haffner SM, Klein R, Moss SE, Klein BE. Sex hormones and the incidence of severe retinopathy in male subjects with type I diabetes. Ophthalmology 1993, 100: 1782-6. (Pubitemid 24004598)
16. Fukui M, Kitagawa Y, Nakamura N, et al. Serum dehydroepiandro-sterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes. Atherosclerosis 2005, 181: 339-44. (Pubitemid 41019615)
17. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus. Endocr J 2008, 55: 667-75.
18. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241: 2035-8. (Pubitemid 9228506)
19. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am J Physiol 1992, 262: E130-3.
20. Paolisso G, Tagliamonte MR, Rizzo MR, et al. Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people. J Am Geriatr Soc 1999, 47: 1312-8. (Pubitemid 29523201)
21. Rosato MT, Schneider SH, Shapses SA. Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int 1998, 63: 107-11. (Pubitemid 28347682)
22. Rieu M, Binoux M. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase. J Clin Endocrinol Metab 1985, 60: 781-5. (Pubitemid 15147570)
23. Dillon JS, Yaney GC, Zhou Y, et al. Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 2000, 49: 2012-20.
24. Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med 1992, 117: 807-11.
25. Ueshiba H, Shimizu Y, Hiroi N, et al. Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus. Eur J Endocrinol 2002, 146: 375-80. (Pubitemid 34257648)
26. Yamauchi A, Takei I, Nakamoto S, et al. Hyperglycemia decreases dehydroepiandrosterone in Japanese male with impaired glucose tolerance and low insulin response. Endocr J 1996, 43: 285-90. (Pubitemid 126527645)
27. Tchernof A, Despres JP, Dupont A, et al. Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue. Diabetes Care 1995, 18: 292-9.
28. Haffner SM, Valdez RA, Mykkanen L, Stern MP, Katz MS. Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 1994, 43: 599-603. (Pubitemid 24145467)
29. Yamauchi A, Takei I, Kasuga A, et al. Depression of dehydroepiandro sterone in Japanese diabetic men - comparison between non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Eur J Endocrinol 1996, 135: 101-4. (Pubitemid 26232713)
30. Boudou P, Sobngwi E, Ibrahim F, et al. Hyperglycaemia acutely decreases circulation dehydroepiandrosterone levels in healthy men. Clin Endocrinol 2006, 64: 46-52.
31. Kameda W, Daimon M, Oizumi T, et al. Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata Study. Metabolism 2005, 54: 669-76. (Pubitemid 40585657)
32. Chiodini I, Di Lembo S, Morelli V, et al. Hypothalamic-pituitaryadrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism 2006, 55: 1135-40. (Pubitemid 44043144)
33. Yard B, Feng Y, Keller H, Mall C, van Der Woude F. Influence of high glucose concentrations on the expression of glycosaminoglycans and N-deacetylase/N-sulphotransferase mRNA in cultured skin fibroblasts from diabetic patients with or without nephropathy. Nephrol Dial Transplant 2002, 17: 386-91. (Pubitemid 34211133)
34. Runge-Morris M, Vento C. Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression. Drug Metab Dispos 1995, 23: 455-9.
35. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978, 253: 2769-76. (Pubitemid 8326483)
36. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999, 15: 314-22. (Pubitemid 29535090)
37. Böni-Schnetzler M, Schmid C, Meier PJ, Froesch ER. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes. Am J Physiol 1991, 260: E846-51.
38. Underwood LE, Thissen JP, Lemozy S, Ketelslegers JM, Clemmons DR. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 1994, 42: 145-51. (Pubitemid 24336142)
39. Kaushal K, Heald AH, Siddals KW, et al. The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome. Diabetes Care 2004, 27: 2682-8. (Pubitemid 39441470)